Correlation Between AGRICULTBK HADR25 and Astellas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AGRICULTBK HADR25 and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AGRICULTBK HADR25 and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AGRICULTBK HADR25 YC and Astellas Pharma, you can compare the effects of market volatilities on AGRICULTBK HADR25 and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AGRICULTBK HADR25 with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AGRICULTBK HADR25 and Astellas Pharma.

Diversification Opportunities for AGRICULTBK HADR25 and Astellas Pharma

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between AGRICULTBK and Astellas is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding AGRICULTBK HADR25 YC and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and AGRICULTBK HADR25 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AGRICULTBK HADR25 YC are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of AGRICULTBK HADR25 i.e., AGRICULTBK HADR25 and Astellas Pharma go up and down completely randomly.

Pair Corralation between AGRICULTBK HADR25 and Astellas Pharma

Assuming the 90 days trading horizon AGRICULTBK HADR25 YC is expected to generate 1.21 times more return on investment than Astellas Pharma. However, AGRICULTBK HADR25 is 1.21 times more volatile than Astellas Pharma. It trades about 0.13 of its potential returns per unit of risk. Astellas Pharma is currently generating about 0.06 per unit of risk. If you would invest  1,200  in AGRICULTBK HADR25 YC on October 20, 2024 and sell it today you would earn a total of  70.00  from holding AGRICULTBK HADR25 YC or generate 5.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

AGRICULTBK HADR25 YC  vs.  Astellas Pharma

 Performance 
       Timeline  
AGRICULTBK HADR25 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in AGRICULTBK HADR25 YC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, AGRICULTBK HADR25 reported solid returns over the last few months and may actually be approaching a breakup point.
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

AGRICULTBK HADR25 and Astellas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AGRICULTBK HADR25 and Astellas Pharma

The main advantage of trading using opposite AGRICULTBK HADR25 and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AGRICULTBK HADR25 position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.
The idea behind AGRICULTBK HADR25 YC and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope